Roslin Technologies develops pluripotent animal stem cells for the cultivated meat industry, providing scalable cell lines that can differentiate into muscle and fat tissues. This technology addresses the growing global demand for sustainable protein by enabling the production of real meat without raising animals, thereby reducing environmental impact and improving animal welfare.
Funding
$33.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The increasing global demand for protein cannot be sustainably met by traditional animal agriculture practices. Conventional meat production methods contribute significantly to environmental degradation, raise animal welfare concerns, and pose risks related to antibiotic use.
Solution
Roslin Technologies develops and supplies pluripotent animal stem cells to cultivated meat producers, enabling the production of real meat directly from cells without raising animals. Their scale-up ready stem cells can self-renew indefinitely and differentiate into muscle and fat tissues. This approach aims to reduce the environmental footprint of meat production, improve animal welfare, and minimize reliance on antibiotics. Roslin Technologies offers cell lines covering beef, pork, and lamb, with seafood in development, including both induced pluripotent stem cells (iPSCs) and embryo-derived stem cells (ESCs).
Target Audience
The primary customers are cultivated meat producers seeking scalable and well-characterized animal cell lines for the production of real meat without traditional animal agriculture.
Features
- Portfolio of pluripotent stem cells for beef, pork, lamb, and seafood (in development)
- Both iPSC and ESC cell lines available
- Provision of cell characterization data to customers
- Development of optimized growth media formulations
- Development of scale-up and differentiation protocols
- Provision of food safety data for regulatory submissions
- Cell banking services
- Bioprocess optimization for large-scale production